bluebird bio, Inc.·4

Jul 3, 4:05 PM ET

Sterling O. James 4

4 · bluebird bio, Inc. · Filed Jul 3, 2024

Insider Transaction Report

Form 4
Period: 2024-07-01
Sterling O. James
Chief Financial Officer
Transactions
  • Award

    Stock Options (Right to buy)

    2024-07-01+300,000300,000 total
    Exercise: $0.98Exp: 2034-07-01Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]This stock option vests over a four-year period at the rate of 25% on July 1, 2025, and then in equal monthly installments for the remaining 36 months.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT